SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Jackmann Natalja)
 

Search: WFRF:(Jackmann Natalja) > (2023) > Vitamin D, bone tur...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Vitamin D, bone turnover markers and hCAP-18 in children with hemato-oncological diseases

Jackmann, Natalja, 1968- (author)
Uppsala universitet,Institutionen för kvinnors och barns hälsa
Frisk, Per, Affiliated Associate professor, 1966- (thesis advisor)
Uppsala universitet,Institutionen för kvinnors och barns hälsa
Mäkitie, Outi, Professor (thesis advisor)
Department of Molecular Medicine and Surgery, Karolinska Institute, and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
show more...
Gustafsson, Jan, Professor emeritus, 1948- (thesis advisor)
Uppsala universitet,Institutionen för kvinnors och barns hälsa
Sällfors Holmqvist, Anna, Affiliated Associate professor (opponent)
Department of Clinical Sciences, Lund University, Lund, Sweden
show less...
 (creator_code:org_t)
ISBN 9789151317854
Uppsala : Acta Universitatis Upsaliensis, 2023
English 61 s.
  • Doctoral thesis (other academic/artistic)
Abstract Subject headings
Close  
  • Children with hemato-oncological diseases may have significant skeletal morbidities. Vitamin D is essential for the maintenance of skeletal health and may also be important for immunological functions and cancer outcomes. As vitamin D deficiency is a recognized problem in children worldwide, it is important to evaluate its prevalence among children and adolescents with hemato-oncological diseases in Sweden.In this thesis, I investigated vitamin D status and its predictors, serum hCAP-18 (the pro-protein of the antimicrobial peptide LL-37 produced during neutrophil differentiation in the bone marrow), and bone turnover markers in children with hemato-oncological diseases at the time of diagnosis. Vitamin D deficiency was found in 30.9–46% of the children. Lower 25-hydroxyvitamin D level correlated with older age, seasons outside summer, a more recent calendar year of sampling, lack of vitamin D supplementation, and country of parental origin located between latitudes -45° and 45°. In preschool children with leukemia, a 25-hydroxyvitamin D level < 50 nmol/L was associated with inferior overall survival. There was no correlation between serum 25-hydroxyvitamin D and hCAP-18 neither in children with hemato-oncological diseases nor in healthy controls. Children with diseases that impair myelopoiesis presented low hCAP-18 levels, whereas those with non-hematological malignancies displayed serum hCAP-18 levels in the same range as that of healthy children.Children diagnosed with leukemia had lower levels of bone formation and resorption markers than those of children with solid tumors or bone marrow failure. Adolescents with osteosarcoma displayed high bone alkaline phosphatase levels.The identification of patients with suboptimal vitamin D status and compromised bone remodeling at cancer diagnosis may aid the development of supportive treatments that reduce the adverse effects of cancer and its treatment. 

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)

Keyword

vitamin D
pediatric cancer
leukemia
bone marrow failure
hCAP-18
bone turnover markers
Medicinsk vetenskap
Medical Science

Publication and Content Type

vet (subject category)
dok (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view